Yu-Li Liu

---

---

Education

1990/08 – 1997/12	Ph.D., Pharmacology, East Tennessee State University, USA
1985/09 – 1987/06	M.S., Pharmacology, National Yang-Ming Medical College, Taiwan

---

Positions

2017/10 – present	Investigator, Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
2012/08 – 2017/09	Associate Investigator, Center for Neuropsychiatric Research, National Health Research Institutes, Miaoli, Taiwan
2011/10 – 2012/07	Associate Investigator, Division of Mental Health and Addiction Medicine, National Health Research Institutes, Miaoli, Taiwan
2007/07 – 2011/09	Assistant Investigator, Division of Mental Health and Addiction Medicine, National Health Research Institutes, Miaoli, Taiwan
2006/03 – 2007/06	Research Associate, Division of Mental Health and Addiction Medicine, National Health Research Institutes, Miaoli, Taiwan
2002/05 – 2006/02	Post-doctor, Department of Medical Research/Psychiatry, National Taiwan University Hospital, Taipei, Taiwan
2001/01 – 2001/12	Clinical Researcher, Department of Education and Research Center, Shin Kong WHS Memorial Hospital, Taipei, Taiwan

---

Expertise

• Schizophrenia genomics
• Psychiatric pharmacogenomics
• Pharmacology
• Therapeutic Drug Monitoring

---

Honors & Awards

2018	Future Technology Breakthrough Award, Future Tech Exhibition of Ministry of Science and Technology – “Drug Discovery Using Artificial Intelligence: Successfully Develop Novel NMDA Modulator for the Treatment of Schizophrenia-Related Symptoms”
2017	Pharmaceutical and New Medical Technology Group, Research and Innovation Award – 13th National Innovation Award, Institute for Biotechnology and Medicine Industry
2015	Second place award in Taiwan Tech Trek
2013	First place award in Taiwan Tech Trek
2009	Best Poster Presentation in TDM at the 11th IATDMCT (International Association of Therapeutic Drug Monitoring and Clinical Toxicology) congress.

---

【Selective Publications】

---

Last Update: 2023-04-01